Exenatide May Reduce Anticipation Of Food, And Increase Satisfaction From Eating.

eports on research presented at the annual meeting of the American Diabetes Association finding that the GLP-1 receptor agonist exenatide (Bydureon, Byetta), may help people with type 2 diabetes lose weight because it “may reduce cravings and increase satisfaction while eating.” The study used functional MRIs to image “the reward centers in the brains of obese individuals with and without type 2 diabetes and measured the response to the anticipation of and drinking of chocolate milk while being given GLP-1 receptor agonist intravenously versus placebo.” Researchers found that the medication “seemed to increase the feeling of reward from food while people were eating.” http://consumer.healthday.com/cognitive-health-information-26/brain-health-news-80/glp-1-receptors-ada-meeting-release-batch-1768-699843.html